<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00780572</url>
  </required_header>
  <id_info>
    <org_study_id>IAB 05-224</org_study_id>
    <nct_id>NCT00780572</nct_id>
  </id_info>
  <brief_title>Implementation of Real-time ADE Surveillance and Decision Support</brief_title>
  <acronym>VA ADE</acronym>
  <official_title>Implementation of Real-Time ADE Surveillance and Decision Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an electronic alerting technology improves time
      to intervention for possible ADEs, identify what factors affect adoption of ADE alerts, and
      whether there is a cost benefit associated with the alerting technology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inpatient adverse drug events (ADEs) continue to be a major source of morbidity and mortality
      despite advances in computerized drug safety measures. Reports on the ability of computerized
      ADE alerts to prevent and mitigate ADEs are lacking. The aims of this project are to 1)
      Assess organizational, social, and cognitive factors that affect adoption of real-time ADE
      alerting technology; 2) Analyze the effect of the ADE alerting technology on management and
      rate of ADEs; and 3) Estimate the cost-benefit of the ADE alerting technology. This study
      will use a patient randomized design of computerized real-time ADE alerts intended for
      primary and secondary prevention of ADEs. The ADE alerts promise to reduce mortality,
      morbidity, and costs due to ADEs. This study will quantify the effect of the alerts in the
      hands of first-year medical residents and pharmacists. The study will explore the
      associations of organizational and soci-cognitive barriers and facilitators with the adoption
      of the ADE alert technology. At the cognitive level, it will explore whether ADE Alerts
      change user bias in diagnosing ADEs or whether the alerts heighten sensitivity to drug
      problems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Intervention Once an ADE Alert Has Fired in CPRS</measure>
    <time_frame>From the time an ADE alert fires in CPRS until the time action has been taken, i.e. an order placed, up to 24 hours.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">595</enrollment>
  <condition>Adverse Drug Events</condition>
  <arm_group>
    <arm_group_label>Arm 1: ADE Alerts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Control/No Alerts</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The second arm is the control. Alerts will not be displayed for these patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ADE alert assistant</intervention_name>
    <description>A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.</description>
    <arm_group_label>Arm 1: ADE Alerts</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All patients admitted to the SLCVAMC at time of study.

        Exclusion Criteria:

        - There are no exclusions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan R. Nebeker, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Health Care Salt Lake City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Health Care Salt Lake City</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>LaFleur J, McAdam-Marx C, Alder SS, Sheng X, Asche CV, Nebeker J, Brixner DI, Silverman SL. Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data. J Bone Miner Metab. 2011 Mar;29(2):193-200. doi: 10.1007/s00774-010-0207-y. Epub 2010 Aug 6.</citation>
    <PMID>20686803</PMID>
  </reference>
  <results_reference>
    <citation>Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M. Out-of-pocket pharmacy expenditures for veterans under medicare part D. Med Care. 2007 Oct;45(10 Supl 2):S77-80.</citation>
    <PMID>17909387</PMID>
  </results_reference>
  <results_reference>
    <citation>Weir CR, Nebeker JR. Critical issues in an electronic documentation system. AMIA Annu Symp Proc. 2007 Oct 11:786-90.</citation>
    <PMID>18693944</PMID>
  </results_reference>
  <results_reference>
    <citation>Nebeker JR, Yarnold PR, Soltysik RC, Sauer BC, Sims SA, Samore MH, Rupper RW, Swanson KM, Savitz LA, Shinogle J, Xu W. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data. Med Care. 2007 Oct;45(10 Supl 2):S81-8.</citation>
    <PMID>17909388</PMID>
  </results_reference>
  <results_reference>
    <citation>Boockvar KS, Livote EE, Goldstein N, Nebeker JR, Siu A, Fried T. Electronic health records and adverse drug events after patient transfer. Qual Saf Health Care. 2010 Oct;19(5):e16. doi: 10.1136/qshc.2009.033050. Epub 2010 Aug 19.</citation>
    <PMID>20724395</PMID>
  </results_reference>
  <results_reference>
    <citation>Kaafarani HM, Rosen AK, Nebeker JR, Shimada S, Mull HJ, Rivard PE, Savitz L, Helwig A, Shin MH, Itani KM. Development of trigger tools for surveillance of adverse events in ambulatory surgery. Qual Saf Health Care. 2010 Oct;19(5):425-9. doi: 10.1136/qshc.2008.031591. Epub 2010 May 31.</citation>
    <PMID>20513790</PMID>
  </results_reference>
  <results_reference>
    <citation>Olola CH, Rowan B, Narus S, Smith M, Hastings T, Poynton M, Nebeker J, Hales J, Evans RS. Implementation of an emergency medical card and a continuity of care report using continuity of care standard. Methods Inf Med. 2009;48(6):519-30. doi: 10.3414/ME09-01-0003. Epub 2009 Nov 5.</citation>
    <PMID>19893849</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2008</study_first_submitted>
  <study_first_submitted_qc>October 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2008</study_first_posted>
  <results_first_submitted>October 15, 2015</results_first_submitted>
  <results_first_submitted_qc>October 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 18, 2015</results_first_posted>
  <last_update_submitted>November 18, 2015</last_update_submitted>
  <last_update_submitted_qc>November 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Safety Management</keyword>
  <keyword>Risk Management</keyword>
  <keyword>surveillance</keyword>
  <keyword>triggers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: ADE Alerts</title>
          <description>Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group
ADE alert assistant: A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Control/No Alerts</title>
          <description>The second arm is the control. Alerts will not be displayed for these patients.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="297"/>
                <participants group_id="P2" count="298"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="297"/>
                <participants group_id="P2" count="298"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: ADE Alerts</title>
          <description>Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group
ADE alert assistant: A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Control/No Alerts</title>
          <description>The second arm is the control. Alerts will not be displayed for these patients.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="297"/>
            <count group_id="B2" value="298"/>
            <count group_id="B3" value="595"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="297"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="595"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <description>No demographics were collected including gender.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female or Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">No demographics were collected including gender.</measurement>
                    <measurement group_id="B2" value="NA">No demographics were collected including gender.</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="297"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="595"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Intervention Once an ADE Alert Has Fired in CPRS</title>
        <time_frame>From the time an ADE alert fires in CPRS until the time action has been taken, i.e. an order placed, up to 24 hours.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: ADE Alerts</title>
            <description>Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group
ADE alert assistant: A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Control/No Alerts</title>
            <description>The second arm is the control. Alerts will not be displayed for these patients.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Intervention Once an ADE Alert Has Fired in CPRS</title>
          <units>hours to intervention</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="297"/>
                <count group_id="O2" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" lower_limit="1.4" upper_limit="25.5"/>
                    <measurement group_id="O2" value="8" lower_limit="1.7" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6680</p_value>
            <method>Regression, Cox</method>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.9396</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.7068</ci_lower_limit>
            <ci_upper_limit>1.2490</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: ADE Alerts</title>
          <description>Arm 1 is a random intervention group in which half of the patients admitted to the VASLCHCS during study time period will be randomly selected. Providers will see ADE alerts for all patient in the randomly selected experimental group
ADE alert assistant: A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Control/No Alert</title>
          <description>The second arm is the control. Alerts will not be displayed for these patients.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="297"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="297"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director HSR&amp;D</name_or_title>
      <organization>VA SLC HCS</organization>
      <phone>801-582-1565</phone>
      <email>IDEAS@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

